-2.92%
Today
Loading 1D prices…
Company profile
CG Oncology Inc. Common stock is classified in Biological Products, (No Diagnostic Substances) within the Health Care sector.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
DALLAS, TX, United States
Fiscal year end
1231
CIK
1991792
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| AMGNAmgen Inc. Common Stock | $207.9B | $36.8B | +20.98% | $14.23 | -1.63% | Hold |
| GILDGilead Sciences Inc. Common Stock | $161.7B | $29.4B | +28.90% | $6.78 | +0.74% | Buy |
| ARGXargenx SE American Depositary Shares | $55.0B | $4.2B | +31.11% | $19.57 | -2.72% | Buy |
| RVMDRevolution Medicines Inc. Common Stock | $38.8B | $0.0 | — | $-5.95 | -2.78% | Buy |
| BIIBBiogen Inc. Common Stock | — | $9.9B | +13.07% | $8.79 | -0.57% | Buy |
